Previous Page  27 / 35 Next Page
Information
Show Menu
Previous Page 27 / 35 Next Page
Page Background

Page 91

Volume 08

Clinical Pharmacology & Biopharmaceutics

ISSN: 2167-065X

Pharmacology 2019

World Heart Congress 2019

August 19-20, 2019

JOINT EVENT

conferenceseries

.com

August 19-20, 2019 Vienna, Austria

&

7

th

World Heart Congress

24

th

World Congress on

Pharmacology

Effects of pre- and postprandial aspirin on gastric bleeding based on clinical data and

in vitro

study

Guangjun Fan, Xueting Wang and Kang Jiang

The Second Hospital of Dalian Medical University, China

Statement of the Problem

: Aspirin is a common anti-inflammatory agent. Clinical pharmacists have found

an inconsistency in the timing of taking the medicine mentioned on the instructions of different brands of

aspirin(100mg). However, there are no relevant research on the medication time of aspirin has been previously

studied. This study aimed to investigate the effect of pre- or postprandial aspirin on GI bleeding, guide clinical

medication, reduce the risk of gastric hemorrhage and protect patients' reasonable rights.

Methodology & Theoretical Orientation

: The rational administration time of enteric-coated aspirin tablets was

explored through retrospective analysis of cases and

in vitro

drug dissolution tests. Data from 100 patients taking

enteric-coated aspirin tablets in the SecondHospital of DalianMedical University were retrospectively analyzed.They

included baseline information, medical history, brand of aspirin, time of taking medicine (fasting or postprandial),

gastric bleeding situation, and so on. Four groups were divided in the study. The Student t test and c2 test were used

for comparison among groups. The

in vitro

study based on high-performance liquid chromatography and basket

method conducted in different pH media (1.0–6.8) simulated changes in gastric pH after a meal, with a basket

rotation speed of 100 rpm. Findings: In this clinical cases, GI bleeding caused by aspirin had no relevance with

the medication time (before or after meals; P < 0.05). The

in vitro

dissolution experiment results suggested that no

obvious release of enteric-coated aspirin tablets occurred at pH 1.0-5.0, when it increased to 6.8, about 80% of the

drug was released. Conclusion & Significance: This study indicated that when the pH of stomach was below 5, aspirin

was not released in advance. Patients with an upset stomach should be advised to take aspirin before meals to prevent

aspirin release in advance and reduce the damage to the stomach.

Clin Pharmacol Biopharm, Volume 08